‘We’d a good finish to 2012, achieving modest growth inside our core business during the fourth quarter, that was a very challenging environment for educational spending. Revenue for eBioscience elevated by 5 percent in comparison with the fourth one fourth of 2011,’ stated Dr. Frank Witney, president & CEO. ‘During the last year we have diversified our portfolio, accomplished our strategic and income goals for our CytoScan products and demonstrated renewed strength in genotyping with this Axiom platform. We intend to return to profitability and growth in fiscal 2013.’ Recent announcements: In December of 2012, the Company prepaid $9.6 million of its senior-secured debts representing the complete principal due in 2013.Sandler, M.D., Nicole Plass, R.N., Deborah L. Stone, M.D., Maria L. Turner, M.D., Suvimol Hill, M.D., John A. Butman, M.D., Ph.D., Rayfel Schneider, M.D., Paul Babyn, M.D., Hatem I. El-Shanti, M.D., Elena Pope, M.D., Karyl Barron, M.D., Xinyu Bing, B.S., Arian Laurence, M.D., Chyi-Chia R. Lee, M.D., Ph.D., Dawn Chapelle, R.N., Gillian I. Clarke, M.D., Kamal Ohson, M.D., Marc Nicholson, M.D., Massimo Gadina, Ph.D., Barbara Yang, B.S., Benjamin D. Korman, B.S., Peter K. Gregersen, M.D., P. Martin van Hagen, M.D., A. Elisabeth Hak, M.D., Marjan Huizing, Ph.D., Proton Rahman, M.D., Daniel C. Douek, M.D., Ph.D., Elaine F. Remmers, Ph.D., Daniel L. Kastner, M.D., Ph.D., and Raphaela Goldbach-Mansky, M.D.10 Some of the autoinflammatory disorders in children, adults, and animal models involve bone and epidermis and manifest with osteomyelitis and pustulosis.